https://www.credenceresearch.com/news/meta-stegra-green-steel-environmental-attribute-certificates-boden-sweden Credence Research en 2026-11-14T14:54:06.000Z Meta Signs Multi-Year Green Steel Certificate Deal With Stegra Tied to Boden Plant https://www.credenceresearch.com/news/fda-approves-roche-gazyva-obinutuzumab-first-drug-primary-membranous-nephropathy Credence Research en 2026-11-14T11:57:53.000Z FDA approves Roche's Gazyva as first drug for primary membranous nephropathy https://www.credenceresearch.com/news/atkinsrealis-candu-energy-tunas-turkiye-nuclear-feasibility-feed-cop31 Credence Research en 2026-11-14T08:55:10.000Z AtkinsRéalis Signs CANDU Nuclear Feasibility and FEED Agreement With Türkiye's TÜNAŞ at COP31 https://www.credenceresearch.com/news/bmw-opens-woodruff-gen6-battery-plant-south-carolina-ix5-us-ev-production Credence Research en 2026-11-14T05:01:39.000Z BMW Opens Woodruff Battery Plant, Starts Gen6 Pack Production for First U.S.-Built Electric BMW https://www.credenceresearch.com/news/fda-approves-astrazeneca-imfinzi-enfortumab-vedotin-cisplatin-ineligible-bladder-cancer-volga Credence Research en 2026-11-14T02:59:56.000Z FDA Approves AstraZeneca's Imfinzi With Enfortumab Vedotin for Cisplatin-Ineligible Bladder Cancer